Stockscreener 앱 받기
316.58
4.07%
-13.42
Krystal Biotech Inc (KRYS) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
2.46%
119.22
|
116.36 | 107.11 | 97.80 | 96.04 |
Operating Expenses
|
2.97%
60.80
|
62.67 | 62.84 | 56.43 | 56.73 |
| Operating Income/Loss |
8.81%
58.42
|
53.69 | 44.27 | 41.37 | 39.31 |
| Income/Loss From Continuing Operations Before Tax |
7.55%
66.08
|
61.44 | 51.13 | 47.97 | 46.77 |
| Income Tax Expense/Benefit |
105.28%
11.31
|
5.51 | -0.269 | -31.40 | 8.442 |
| Net Income/Loss |
2.08%
54.77
|
55.93 | 51.40 | 79.36 | 38.33 |
| Basic Average Shares |
0.82%
29.53
|
29.29 | 0.051 | 28.95 | 28.91 |
| Diluted Average Shares |
0.49%
30.66
|
30.51 | 0.122 | 29.83 | 29.75 |
| Basic Earnings Per Share |
3.14%
1.85
|
1.91 | 1.77 | 2.74 | 1.33 |
| Diluted Earnings Per Share |
2.19%
1.79
|
1.83 | 1.70 | 2.66 | 1.29 |
8.20%
자본화:
|
볼륨(24시간):